Ripretinib in Chinese Patients With Advanced GIST: a Real World Study
Clinical trial NCT05697107 · UNKNOWN
Trial details
- NCT number
- NCT05697107
- Sponsor
- Peking University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-05-20
- Primary completion
- 2022-08-30
- Enrollment
- 308
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.